Dr. Mona-Katharina Bill

Dr. Mona-Katharina Bill is a Senior Scientist in Analytical Chemistry at Silence Therapeutics plc. Prior to this role, Dr. Mona-Katharina worked as a Doktorandin at Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie IME, focusing on the isolation and characterization of new antibacterial active secondary metabolites. Dr. Mona-Katharina also completed a Masterarbeit at Sanofi, where Dr. Mona-Katharina optimized the nitrogen determination of Protaminsulfat for use in the production of NPH-insulin for the treatment of diabetes mellitus. Dr. Bill holds a Master of Science in Biomedizinische Chemie from Johannes Gutenberg University Mainz.